The Ohio State University | Oncology Update

Byrd Wins Major National Award for Clinical Cancer Research

John C. Byrd, MD

John C. Byrd, MD, professor and director of the Division of Hematology at Ohio State and co-leader of the Leukemia Research Program at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), received the 21st Annual Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research during a ceremony at the American Association of Cancer Research (AACR) Annual Meeting (April 16-20) in New Orleans.

Established in 1996, the award is named for the late Joseph H. Burchenal, MD, honorary member and past president of the AACR, who was a major figure in clinical cancer research and chemotherapy. As this year’s recipient, Byrd delivered his award lecture, “Targeting BTK in CLL: A New Treatment Paradigm,” on April 19.

On May 4, Byrd, who also holds the D. Warren Brown Designated Chair in Leukemia Research, was named a 2016 Distinguished University Professor, the highest honor that Ohio State bestows on a faculty member. To date, only 53 other faculty members have held the Distinguished University Professor title.

A member of the National Cancer Institute’s Leukemia Steering Committee, Byrd is chair of the Leukemia Correlative Sciences Committee within the Alliance for Clinical Trials in Oncology and a member of the American Society for Clinical Investigation. He has published more than 400 papers related to clinical and laboratory investigation of acute myeloid leukemia and chronic lymphocytic leukemia. In 2014, Byrd was rated in the top 10 percent of physicians in the nation for patient satisfaction.                                  

© 2024 The Ohio State University Comprehensive Cancer Center –
James Cancer Hospital and Solove Research Institute
460 W. 10th Ave.
Columbus, Ohio 43210

cancer.osu.edu
News & Media
Contact Us
Research & Education
Find a Clinical Trial
Referrals to Ohio State
Patient Support